抑郁症状与总医疗费用:功能受限与多病共存的作用
该前瞻性队列研究纳入2508名社区居住老年女性,分析抑郁症状与后续12个月总医疗费用的关联。结果显示,轻度抑郁症状者调整后费用比1.34(95%CI 1.14-1.59),中重度者费用比1.29(95%CI 0.99-1.69),部分归因于功能受限和多病共存。
要点
- 轻度抑郁症状(GDS 2-5分)与后续总医疗费用升高独立相关。
- 功能受限和多病共存部分解释了抑郁症状与高医疗费用的关联。
- 中重度抑郁症状与费用升高的关联在调整后不再显著。
核心结论
- 抑郁症状与后续较高的医疗费用相关,部分归因于功能受限和多病共存。
- 即使轻度抑郁症状也与较高的医疗费用相关。
研究设计与样本
- 前瞻性队列研究(骨质疏松性骨折研究SOF),纳入2508名社区居住老年女性(平均年龄79.4岁),链接Medicare理赔数据。
主要发现
- 调整年龄、站点、自报功能受限和多病共存后,轻度抑郁症状者费用比1.34(95%CI 1.14-1.59),中重度者费用比1.29(95%CI 0.99-1.69)。
关键数值与推荐
- 抑郁症状采用15项老年抑郁量表(GDS)评估,分为0-1分、2-5分、6分及以上三组。
- 功能受限采用工具性日常生活活动能力受损数目(范围0-5)评估。
- 多病共存采用Elixhauser方法基于Y10检查前12个月理赔数据确定。
临床怎么用
- 对老年女性患者,即使轻度抑郁症状也应关注其后续医疗费用风险。
- 评估抑郁症状时需同时考虑功能受限和多病共存对费用的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Depressive symptoms can be both a cause and a consequence of functional limitations and medical conditions. Our objectives were to determine the association of depressive symptoms with subsequent total healthcare costs in older women after accounting for functional limitations and multimorbidity. DESIGN: Prospective cohort study (Study of Osteoporotic Fractures [SOF]). SETTING: Four US sites. PARTICIPANTS: A total of 2508 community-dwelling women (mean age = 79.4 years) participating in the SOF year 10 (Y10) examination linked with their Medicare claims data. MEASUREMENTS: At Y10, depressive symptoms were measured using the 15-item Geriatric Depression Scale (GDS) and functional limitations were assessed by number (range = 0-5) of impairments in performing instrumental activities of daily living. Multimorbidity was ascertained by the Elixhauser method using claims data for the 12 months preceding the Y10 examination. Total direct healthcare costs, outpatient costs, acute hospital stays, and skilled nursing facility during the 12 months following the Y10 examination were ascertained from claims data. RESULTS: Annualized mean (SD) total healthcare costs were $4654 ($9075) in those with little or no depressive symptoms (GDS score = 0-1), $7871 ($14 534) in those with mild depressive symptoms (GDS score = 2-5), and $9010 ($15 578) in those with moderate to severe depressive symptoms (GDS score = 6 or more). After adjustment for age, site, self-reported functional limitations, and multimorbidity, the magnitudes of these incremental costs were partially attenuated (cost ratio = 1.34 [95% confidence interval {CI} = 1.14-1.59] for those with mild depressive symptoms, and cost ratio = 1.29 [95% CI = 0.99-1.69] for those with moderate to severe depressive symptoms vs women with little or no depressive symptoms). CONCLUSION: Depressive symptoms were associated with higher subsequent healthcare costs attributable, in part, to greater functional limitations and multimorbidity among those with symptoms. Importantly, even mild depressive symptoms were associated with higher healthcare costs. J Am Geriatr Soc 67:1596-1603, 2019.
引用
- Schousboe JT, Vo TN, Kats AM, et al. Depressive Symptoms and Total Healthcare Costs: Roles of Functional Limitations and Multimorbidity. J Am Geriatr Soc. 2019. PMID: 30903701. doi:10.1111/jgs.15881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。